Norwegian and Nordic Lung Cancer Insights – October Update
This overview compiles recent Norwegian and Nordic research in lung cancer. The Norwegian studies address end-of-life systemic treatment patterns, national trends in radiotherapy use, and biomarker-based prognostication in small-cell lung cancer, alongside international benchmarking of chemotherapy and radiotherapy utilization. Nordic collaborative studies provide comparative registry-based analyses of lung cancer epidemiology, care delivery, and survival across Denmark, Finland, Norway, and Sweden.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
